Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

NCT02475213

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • Mayo Clinic - AZ Scottsdale, Arizona, United States
  • Christiana Care Health Services, Inc. Newark, Delaware, United States
  • Mayo Clinic - FL Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 20 locations
View Trial Details
Completed

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

NCT01261728

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • Hartford Hospital (Data Collection Only) Hartford, Connecticut, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT05585034

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +58 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View Trial Details
Completed

A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)

NCT05524545

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusett's General Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Completed

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

NCT05902494

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute - School of Medicine Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

NCT03502785

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

NCT03988309

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Institute of Urology, USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Avant Concierge Urology Winter Garden, Florida, United States
  • Accellacare Chicago, Illinois, United States
  • Allina Health Cancer Institute Minneapolis, Minnesota, United States
View Trial Details
Completed

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

NCT04383938

Conditions
Advanced Solid Tumor, Bladder Cancer, Bronchial Neoplasms, +32 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions